Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models.

Abstract:

:ADAMTS13 metalloprotease cleaves von Willebrand factor (VWF), thereby inhibiting platelet aggregation and arterial thrombosis. An inability to cleave ultralarge VWF resulting from hereditary or acquired deficiency of plasma ADAMTS13 activity leads to a potentially fatal syndrome, thrombotic thrombocytopenic purpura (TTP). Plasma exchange is the most effective initial therapy for TTP to date. Here, we report characterization of transgenic mice expressing recombinant human ADAMTS13 (rADAMTS13) in platelets and its efficacy in inhibiting arterial thrombosis and preventing hereditary and acquired antibody-mediated TTP in murine models. Western blotting and fluorescent resonance energy transfer assay detect full-length rADAMTS13 protein and its proteolytic activity, respectively, in transgenic (Adamts13(-/-)Plt(A13)), but not in wild-type and Adamts13(-/-), platelets. The expressed rADAMTS13 is released on stimulation with thrombin and collagen, but less with 2MesADP. Platelet-delivered rADAMTS13 is able to inhibit arterial thrombosis after vascular injury and prevent the onset and progression of Shigatoxin-2 or recombinant murine VWF-induced TTP syndrome in mice despite a lack of plasma ADAMTS13 activity resulting from the ADAMTS13 gene deletion or the antibody-mediated inhibition of plasma ADAMTS13 activity. These findings provide a proof of concept that platelet-delivered ADAMTS13 may be explored as a novel treatment of arterial thrombotic disorders, including hereditary and acquired TTP, in the presence of anti-ADAMTS13 autoantibodies.

journal_name

Blood

journal_title

Blood

authors

Pickens B,Mao Y,Li D,Siegel DL,Poncz M,Cines DB,Zheng XL

doi

10.1182/blood-2014-07-587139

subject

Has Abstract

pub_date

2015-05-21 00:00:00

pages

3326-34

issue

21

eissn

0006-4971

issn

1528-0020

pii

blood-2014-07-587139

journal_volume

125

pub_type

杂志文章

相关文献

BLOOD文献大全
  • High-dose cyclophosphamide for refractory autoimmune hemolytic anemia.

    abstract::High-dose cyclophosphamide, without stem cell rescue, has been used successfully to treat aplastic anemia and other autoimmune disorders. To determine the safety and efficacy of high-dose cyclophosphamide among patients with severe refractory autoimmune hemolytic anemia, we treated 9 patients with cyclophosphamide (50...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-01-0087

    authors: Moyo VM,Smith D,Brodsky I,Crilley P,Jones RJ,Brodsky RA

    更新日期:2002-07-15 00:00:00

  • Heterogeneity in human prothrombin: analysis of cause.

    abstract::Two fractions of human prothrombin can be isolated from single donor plasma by the technique of heparin-agarose chromatography in (sodium) citrate buffer, pH 7.5, as previously reported for pooled plasma. The two fractions, designated H-II1 and H-II2, are found in a ratio of approximately 4:1. Both forms comigrate in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bajaj SP,Rapaport SI,Prodonos C,Russell WA

    更新日期:1981-11-01 00:00:00

  • Evidence for separate calcium-signaling P2T and P2U purinoceptors in human megakaryocytic Dami cells.

    abstract::Recently (J Pharmacol Exp Ther 261:580, 1992), we have shown that K562 leukemia cells express a calcium-signaling purinoceptor with characteristics of the P2T receptor subtype for adenosine diphosphate (ADP) previously found only in platelets. Because these results suggested that the P2T receptor may be an early marke...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Murgo AJ,Contrera JG,Sistare FD

    更新日期:1994-03-01 00:00:00

  • Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation.

    abstract::Complement plays a key role in host defense, but its dysregulation can cause autologous tissue injury. Complement activation is normally controlled by regulatory proteins, including factor H (FH) in plasma and membrane cofactor protein (MCP) on the cell surface. Mutations in FH and MCP are linked to atypical hemolytic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-07-728253

    authors: Ueda Y,Mohammed I,Song D,Gullipalli D,Zhou L,Sato S,Wang Y,Gupta S,Cheng Z,Wang H,Bao J,Mao Y,Brass L,Zheng XL,Miwa T,Palmer M,Dunaief J,Song WC

    更新日期:2017-03-02 00:00:00

  • The AKT kinase is activated in multiple myeloma tumor cells.

    abstract::Immunohistochemistry (IHC) was performed on archived bone marrow (BM) with a phosphospecific anti-AKT antibody. IHC on 26 BM biopsies from patients with multiple myeloma (MM) demonstrated phospho-AKT staining of malignant plasma cells in a cell membrane-specific pattern, whereas nonmalignant hematopoietic cells did no...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.9.2853

    authors: Hsu J,Shi Y,Krajewski S,Renner S,Fisher M,Reed JC,Franke TF,Lichtenstein A

    更新日期:2001-11-01 00:00:00

  • Persistent epstein-barr virus infection mimicking juvenile chronic myelogenous leukemia: immunologic and hematologic studies.

    abstract::Epstein-Barr virus (EBV) infections may induce a diverse clinical picture, ranging from the well characterized infectious mononucleosis (IM) syndrome to the rare X-linked lymphoproliferative syndrome. We describe two unrelated children, a 21-mo-old white boy and a 15-mo-old black girl, who presented with the clinical ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Herrod HG,Dow LW,Sullivan JL

    更新日期:1983-06-01 00:00:00

  • Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification.

    abstract::Multisystem Langerhans cell histiocytosis (MS-LCH) is associated with high mortality when patients have risk organ involvement (RO(+)) or are younger than 2 years. In an international randomized trial, LCH-II, we intensified their treatment: arm A consisted of 6 weeks of daily prednisone and weekly vinblastine followe...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2007-08-106211

    authors: Gadner H,Grois N,Pötschger U,Minkov M,Aricò M,Braier J,Broadbent V,Donadieu J,Henter JI,McCarter R,Ladisch S,Histiocyte Society.

    更新日期:2008-03-01 00:00:00

  • Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial.

    abstract::In the 2005-01 trial, we have demonstrated that bortezomib-dexamethasone as induction therapy before autologous stem cell transplantation was superior to vincristine-adriamycin-dexamethasone. We conducted a post-hoc analysis to assess the prognostic impact of initial characteristics as well as response to therapy in p...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2010-08-300863

    authors: Moreau P,Attal M,Pégourié B,Planche L,Hulin C,Facon T,Stoppa AM,Fuzibet JG,Grosbois B,Doyen C,Ketterer N,Sebban C,Kolb B,Chaleteix C,Dib M,Voillat L,Fontan J,Garderet L,Jaubert J,Mathiot C,Esseltine D,Avet-Loise

    更新日期:2011-03-17 00:00:00

  • Identification of human lymphoma cells by antisera to malignancy-associated nucleolar antigens.

    abstract::The non-Hodgkin's lymphomas (NHL) are a diverse group of human lymphoid neoplasms that have long presented pathologists with formidable diagnostic challenges. These tumors of the immune system are thought to represent neoplastic transformations of most of the recognized stages in T and B lymphocyte ontogeny. Lymphoma ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ford RJ,Cramer M,Davis FM

    更新日期:1984-03-01 00:00:00

  • Mouse and human HSPC immobilization in liquid culture by CD43- or CD44-antibody coating.

    abstract::Keeping track of individual cell identifications is imperative to the study of dynamic single-cell behavior over time. Highly motile hematopoietic stem and progenitor cells (HSPCs) migrate quickly and do not adhere, and thus must be imaged very frequently to keep cell identifications. Even worse, they are also flushed...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-07-794131

    authors: Loeffler D,Wang W,Hopf A,Hilsenbeck O,Bourgine PE,Rudolf F,Martin I,Schroeder T

    更新日期:2018-03-29 00:00:00

  • Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.

    abstract::Enforced BCL-2 gene expression in leukemic cell lines suppresses apoptosis and confers resistance to anticancer drugs, but the clinical significance of increased BCL-2 protein levels in acute lymphoblastic leukemia (ALL) is unknown. Among 52 children with newly diagnosed ALL, BCL-2 expression in leukemic lymphoblasts ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Coustan-Smith E,Kitanaka A,Pui CH,McNinch L,Evans WE,Raimondi SC,Behm FG,Aricò M,Campana D

    更新日期:1996-02-01 00:00:00

  • Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.

    abstract::To study outcomes of adults with idiopathic thrombocytopenic purpura (ITP), we performed a follow-up study in a cohort of 152 consecutive patients who were treated according to a well-defined algorithm. Long-term outcomes were determined relative to the response 2 years after diagnosis, because most (93%) patients who...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.9.2549

    authors: Portielje JE,Westendorp RG,Kluin-Nelemans HC,Brand A

    更新日期:2001-05-01 00:00:00

  • Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells.

    abstract::Because of their potent immunoregulatory capacity, dendritic cells (DCs) have been exploited as therapeutic tools to boost immune responses against tumors or pathogens, or dampen autoimmune or allergic responses. Murine bone marrow-derived DCs (BM-DCs) are the closest known equivalent of the blood monocyte-derived DCs...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-204321

    authors: Creusot RJ,Yaghoubi SS,Chang P,Chia J,Contag CH,Gambhir SS,Fathman CG

    更新日期:2009-06-25 00:00:00

  • Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.

    abstract::In a prospective trial in 284 children with B-lineage acute lymphoblastic leukemia (ALL), we assessed the clinical utility of real-time quantitative polymerase chain reaction analysis of antigen receptor gene rearrangements for detection of minimal residual disease (MRD) to identify children at high risk of relapse. A...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2006-09-045369

    authors: Zhou J,Goldwasser MA,Li A,Dahlberg SE,Neuberg D,Wang H,Dalton V,McBride KD,Sallan SE,Silverman LB,Gribben JG,Dana-Farber Cancer Institute ALL Consortium.

    更新日期:2007-09-01 00:00:00

  • Identification and characterization of a high-affinity granulocyte-macrophage colony-stimulating factor receptor on primary rat oligodendrocytes.

    abstract::We previously showed the presence of receptors for granulocyte-macrophage colony-stimulating factor (GM-CSF) on tumor tissues and tumor cell lines that are derived from the neural crest. To determine whether normal neural cells express functional GM-CSF receptors, we isolated and analyzed primary rat brain cells, incl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Baldwin GC,Benveniste EN,Chung GY,Gasson JC,Golde DW

    更新日期:1993-12-01 00:00:00

  • p53 abnormalities in splenic lymphoma with villous lymphocytes.

    abstract::The incidence and role of p53 abnormalities have not been reported in splenic lymphoma with villous lymphocytes (SLVL), the leukemic counterpart of splenic marginal zone lymphoma. Because p53 abnormalities correlate with progressive and refractory disease in cancer and isochromosome 17q has been described in SLVL, a l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.11.3552

    authors: Gruszka-Westwood AM,Hamoudi RA,Matutes E,Tuset E,Catovsky D

    更新日期:2001-06-01 00:00:00

  • Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa.

    abstract::Glanzmann thrombasthenia (GT) is the most common inherited disorder of platelets. Most of the molecular defects previously identified in GT have been caused by point (or other small) mutations in the genes for glycoprotein (GP) IIb or GPIIIa. We have used single-strand conformation polymorphism (SSCP) analysis to rapi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jin Y,Dietz HC,Nurden A,Bray PF

    更新日期:1993-10-15 00:00:00

  • How I treat venous thromboembolism in patients with cancer.

    abstract::Venous thromboembolism (VTE) is a frequent complication in cancer patients and represents an important cause of morbidity and mortality. Especially in patients who have a poor life expectancy, preventing death from pulmonary embolism is the mainstay of treatment. Critically ill patients should promptly be administered...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1508

    authors: Prandoni P

    更新日期:2005-12-15 00:00:00

  • Structural requirements for the activation of human factor VIII by thrombin.

    abstract::The coagulation factors V (FV) and VIII (FVIII) are important at sites of vascular injury for the amplification of the clotting cascade. Natural variants of these factors frequently lead to severe bleeding disorders. To understand the mechanisms of activation of FVIII by thrombin, we used a bank of mutant thrombins to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0843

    authors: Myles T,Yun TH,Leung LL

    更新日期:2002-10-15 00:00:00

  • Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.

    abstract::Recombinant human macrophage colony-stimulating factor (rhM-CSF) was given to cynomolgus monkeys by continuous intravenous infusion or subcutaneous injection, at a dose of 50 to 100 micrograms/kg/d in repetitive 14-day cycles. Starting within 24 to 48 hours of initiation of rhM-CSF, there was a progressive increase in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Munn DH,Garnick MB,Cheung NK

    更新日期:1990-05-15 00:00:00

  • Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

    abstract::Type 3 von Willebrand disease (VWD) is a severe hemorrhagic defect in humans. We now identify the homozygous mutation in the Chapel Hill strain of canine type 3 VWD that results in premature termination of von Willebrand factor (VWF) protein synthesis. We cultured endothelium from VWD and normal dogs to study intracel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0464

    authors: Haberichter SL,Merricks EP,Fahs SA,Christopherson PA,Nichols TC,Montgomery RR

    更新日期:2005-01-01 00:00:00

  • The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients.

    abstract::We have previously determined that in African sickle cell anemia (SS) patients three different beta-like globin gene cluster haplotypes are associated with different percent G gamma (one of the two types of non-alpha chains comprising hemoglobin F [HbF]), mean percent HbF, and percent dense cells. We report now that i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nagel RL,Erlingsson S,Fabry ME,Croizat H,Susuka SM,Lachman H,Sutton M,Driscoll C,Bouhassira E,Billett HH

    更新日期:1991-03-15 00:00:00

  • Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans.

    abstract::Vascular calcification is a marker of increased cardiovascular risk. Vitamin K-dependent matrix Gla protein (MGP) is important in inhibiting calcification. Because MGP activation is vitamin K dependent, we performed a cross-sectional study investigating the relationship between the use of vitamin K antagonists and ext...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-264598

    authors: Rennenberg RJ,van Varik BJ,Schurgers LJ,Hamulyak K,Ten Cate H,Leiner T,Vermeer C,de Leeuw PW,Kroon AA

    更新日期:2010-06-17 00:00:00

  • Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia.

    abstract::The primary objective was to describe the prevalence and characteristics of microbiologically defined infections and infection-related mortality (IRM) in 492 children with acute myeloid leukemia enrolled on CCG 2961. Secondary objectives were to determine the relationship between demographic, disease-related, and ther...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2007-05-091942

    authors: Sung L,Lange BJ,Gerbing RB,Alonzo TA,Feusner J

    更新日期:2007-11-15 00:00:00

  • Monoclonal antibody definition of T cell acute leukemia: a Pediatric Oncology Group study.

    abstract::Leukemic blasts from 774 children with newly diagnosed acute lymphocytic leukemia (ALL) have been phenotyped by microcytotoxicity testing with a panel of monoclonal antibodies and heteroantisera as part of a Pediatric Oncology Group classification study of acute leukemia. One hundred twenty-two cases, or 16% were desi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Borowitz MJ,Dowell BL,Boyett JM,Falletta JM,Pullen DJ,Crist WM,Humphrey GB,Metzgar RS

    更新日期:1985-04-01 00:00:00

  • Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

    abstract::Using data from ARISTOTLE, we describe the periprocedural management of anticoagulation and rates of subsequent clinical outcomes among patients chronically anticoagulated with warfarin or apixaban. We recorded whether (and for how long) anticoagulant therapy was interrupted preprocedure, whether bridging therapy was ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2014-08-595496

    authors: Garcia D,Alexander JH,Wallentin L,Wojdyla DM,Thomas L,Hanna M,Al-Khatib SM,Dorian P,Ansell J,Commerford P,Flaker G,Lanas F,Vinereanu D,Xavier D,Hylek EM,Held C,Verheugt FW,Granger CB,Lopes RD

    更新日期:2014-12-11 00:00:00

  • Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.

    abstract::To prospectively evaluate allogeneic stem cell transplantation (allo-SCT) for myeloma as part of first-line therapy, a donor versus no-donor analysis was performed of patients treated in the HOVON-50 study, a study that was originally designed to examine thalidomide combined with intensive therapy. Two hundred sixty p...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-11-393801

    authors: Lokhorst HM,van der Holt B,Cornelissen JJ,Kersten MJ,van Oers M,Raymakers R,Minnema MC,Zweegman S,Janssen JJ,Zijlmans M,Bos G,Schaap N,Wittebol S,de Weerdt O,Ammerlaan R,Sonneveld P

    更新日期:2012-06-28 00:00:00

  • Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.

    abstract::Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with recognized variability in clinical outcome, genetic features, and cells of origin. To date, transcriptional profiling has been used to highlight similarities between DLBCL tumor cells and normal B-cell subtypes and associate genes and pathways with ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-07-2947

    authors: Monti S,Savage KJ,Kutok JL,Feuerhake F,Kurtin P,Mihm M,Wu B,Pasqualucci L,Neuberg D,Aguiar RC,Dal Cin P,Ladd C,Pinkus GS,Salles G,Harris NL,Dalla-Favera R,Habermann TM,Aster JC,Golub TR,Shipp MA

    更新日期:2005-03-01 00:00:00

  • Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation.

    abstract::Cellular oxygen partial pressure is sensed by a family of prolyl-4-hydroxylase domain (PHD) enzymes that modify hypoxia-inducible factor (HIF)alpha subunits. Upon hydroxylation under normoxic conditions, HIFalpha is bound by the von Hippel-Lindau tumor suppressor protein and targeted for proteasomal destruction. Since...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-3980

    authors: Martin F,Linden T,Katschinski DM,Oehme F,Flamme I,Mukhopadhyay CK,Eckhardt K,Tröger J,Barth S,Camenisch G,Wenger RH

    更新日期:2005-06-15 00:00:00

  • Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.

    abstract::Autologous stem-cell transplantation has become a widely used therapy in Hodgkin's disease (HD). To appreciate the early and late risks associated with this procedure, its lethal toxicity and effects on the incidence of secondary cancers were studied. Data related to 467 French patients grafted from 1982 to 1995 for p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: André M,Henry-Amar M,Blaise D,Colombat P,Fleury J,Milpied N,Cahn JY,Pico JL,Bastion Y,Kuentz M,Nedellec G,Attal M,Fermé C,Gisselbrecht C

    更新日期:1998-09-15 00:00:00